Filters

Magnus Christensen, Gunnel Tybring, Kazuo Mihara, Norio Yasui-Furokori, Juan Antonio Carrillo, Sara I Ramos, Katarina Andersson, Marja-Liisa Dahl, Leif Bertilsson

Clinical pharmacology and therapeutics 2002;71(3):141-52

Full Text

Abstract

A herbal-drug interaction study of keishi-bukuryo-gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers.

Junji Saruwatari, Chisato Takaishi, Kousuke Yoshida, Ayaka Takashima, Youhei Fujimura, Yuichiro Umemoto, Tomohiro Abe, Masataka Kitamado, Masatsugu Shimomasuda, Yousuke Muramoto, Kazuko Nakagawa

The Journal of pharmacy and pharmacology 2012;64(5):670-6

Full Text

Abstract

Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation?

D A Fairman, C Collins, S Chapple

Drug metabolism and disposition: the biological fate of chemicals 2008;35(12):2159-65

Full Text

Abstract

Results: 1 – 15 / 19

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Cytochrome P-450 CYP1A2 Inhibitors""[mesh_terms]

Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers.

Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development.

Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons.

Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients.

Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.

A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects.

Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: a case report.

Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.

Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo.

The multikinase inhibitor axitinib is a potent inhibitor of human CYP1A2.

In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects.

Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.

Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19).

A herbal-drug interaction study of keishi-bukuryo-gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers.

Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation?

Results for
""Cytochrome P-450 CYP1A2 Inhibitors""[mesh_terms]